Vogisir M 500mg/0.3mg Tablet SR
Marketer
Medcure Pharma
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Vogisir M 500mg/0.3mg Tablet SR
Vogisir M 500mg/0.3mg sustained-release tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage will be determined and potentially adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels and potential complications such as renal impairment, vision loss, neuropathy, and limb amputation. Remember, this medication forms part of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Potential side effects, including nausea, altered taste perception, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes, are typically transient and self-limiting. Persistent or concerning side effects warrant immediate medical attention; your physician can offer strategies for managing or treating these symptoms. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Prior heart disease should be disclosed to your physician before commencing treatment, as suitability may be affected. Pregnant or lactating women must consult their physician before using this medication. Regular blood glucose monitoring is essential, and supplementary blood tests to track blood cell counts and liver function may be recommended by your doctor.
Primary Ingredients of Vogisir M 500mg/0.3mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Vogisir M 500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Vogisir M 500mg/0.3mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vogisir M 500mg/0.3mg Extended-Release tablets should be administered with a meal.
Common Side effects of Vogisir M 500mg/0.3mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Vogisir M 500mg/0.3mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vogisir M 500mg/0.3mg Extended-Release Tablets should be administered with a meal.
How Vogisir M 500mg/0.3mg Tablet SR works:
Vogisir M 500mg/0.3mg sustained-release tablets contain a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vogisir M 500mg/0.3mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Vogisir M 500mg/0.3mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Vogisir M 500mg/0.3mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk with the possibility of infant harm.
DrivingSAFE
Driving ability is typically unaffected by Vogisir M 500mg/0.3mg SR Tablets. Nevertheless, patients should be aware of the potential for low blood sugar (hypoglycemia) if this medication is taken concurrently with other diabetes treatments like sulfonylureas, insulin, or repaglinide.
KidneyCAUTION
Patients with kidney impairment should use Vogisir M 500mg/0.3mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Vogisir M 500mg/0.3mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Vogisir M 500mg/0.3mg Tablet SR use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Vogisir M 500mg/0.3mg Tablet SR :
Should you forget to take a Vogisir M 500mg/0.3mg Tablet SR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.
Facts to Know About Vogisir M 500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently